Back to Search
Start Over
1439TiP A randomized, double-blinded, placebo-controlled phase III trial of HX008 plus irinotecan as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma
- Source :
- Annals of Oncology. 32:S1075
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
Details
- ISSN :
- 09237534
- Volume :
- 32
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi...........4788d15e8dc58f3bfcf62d7e8a5c84ba
- Full Text :
- https://doi.org/10.1016/j.annonc.2021.08.1548